Comparative profiling of the gene expression for estrogen responsiveness in cultured human cell lines

Toxicology in Vitro

Volumn 21, Issue 4, 2007, Pages 741-752

  Inoue, Akio ^a   Seino, Yuko ^b,c   Terasaka, Shunichi ^a   Hayashi, Shin ichi ^c,d   Yamori, Takao ^e   Tanji, Masao ^a   Kiyama, Ryoiti ^a,b  

^a InfoGenes Co Ltd   (Japan)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^c SAITAMA CANCER CENTER   (Japan)

^d TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e CANCER CHEMOTHERAPY CENTER   (Japan)

Author keywords

Cultured cells; Endocrine disruptor; Estrogen; Estrogenicity; Expression profile; Focused microarray

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; DIETHYLSTILBESTROL; ESTRADIOL; ESTROGEN;

ARTICLE; CELL CULTURE; CELL LINE; CELL STRAIN MCF 7; CONTROLLED STUDY; ENDOMETRIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; KIDNEY CELL;

BIOLOGICAL TRANSPORT, ACTIVE; CELL LINE; CELL PROLIFERATION; DATA INTERPRETATION, STATISTICAL; DNA, COMPLEMENTARY; ESTROGENS, NON-STEROIDAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION;

EID: 34047260119     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2007.01.014     Document Type: Article

References (54)

1. Blair R.M., Fang H., Branham W.S., Hass B.S., Dial S.L., Moland C.L., Tong W., Shi L., Perkins R., and Sheehan D.M. The estrogen receptor relative binding affinities of 188 natural and xenochemicals: structural diversity of ligands. Toxicological Sciences 54 (2000) 138-153
2. Bramlett K.S., and Burris T.P. Target specificity of selective estrogen receptor modulators within human endometrial cancer cells. The Journal of Steroid Biochemistry and Molecular Biology 86 (2003) 27-34
3. Cicatiello L., Scafoglio C., Altucci L., Cancemi M., Natoli G., Facchiano A., Iazzetti G., Calogero R., Biglia N., De Bortoli M., Sfiligoi C., Sismondi P., Bresciani F., and Weisz A. A genomic view of estrogen actions in human breast cancer cells by expression profiling of the hormone-responsive transcriptome. Journal of Molecular Endocrinology 32 (2004) 719-775
4. Cunliffe H.E., Ringner M., Bilke S., Walker R.L., Cheung J.M., Chen Y., and Meltzer P.S. The gene expression response of breast cancer to growth regulators: patterns and correlation with tumor expression profiles. Cancer Research 63 (2003) 7158-7166
5. Cuzick J. Future possibilities in the prevention of breast cancer: breast cancer prevention trials. Breast Cancer Research 2 (2000) 258-263
6. Delcommenne M., Tan C., Gray V., Rue L., Woodgett J., and Dedhar S. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proceedings of the National Academy of Sciences of the United States of America 95 (1998) 11211-11216
7. De Servi B., Hermani A., Medunjanin S., and Mayer D. Impact of PKCdelta on estrogen receptor localization and activity in breast cancer cells. Oncogene 24 (2005) 4946-4955
8. Eason R.R., Till S.R., Velarde M.C., Geng Y., Chatman L., Gu Jr. L., Badger T.M., Simmen F.A., and Simmen R.C. Uterine phenotype of young adult rats exposed to dietary soy or genistein during development. The Journal of Nutritional Biochemistry 16 (2005) 625-632
9. Eisen M.B., Spellman P.T., Brown P.O., and Botstein D. Cluster analysis and display of genome-wide expression patterns. Proceedings of the National Academy of Sciences of the United States of America 95 (1998) 14863-14868
10. Forsyth I.A. The insulin-like growth factor and epidermal growth factor families in mammary cell growth in ruminants: action and interaction with hormones. Journal of Dairy Science 79 (1996) 1085-1096
11. Frodin M., and Gammeltoft S. Role and regulation of 90 kDa ribosomal S6 kinase (RSK) in signal transduction. Molecular and Cellular Endocrinology 151 (1999) 65-77
12. Fujimoto N., Igarashi K., Kanno J., Honda H., and Inoue T. Identification of estrogen-responsive genes in the GH3 cell line by cDNA microarray analysis. The Journal of Steroid Biochemistry and Molecular Biology 91 (2004) 121-129
13. Furuya Y., Kohno N., Fujiwara Y., and Saitoh Y. Mechanisms of estrogen action on the proliferation of MCF-7 human breast cancer cells in an improved culture medium. Cancer Research 49 (1989) 6670-6674
14. Gee J.M., Robertson J.F., Gutteridge E., Ellis I.O., Pinder S.E., Rubini M., and Nicholson R.I. Epidermal growth factor receptor/HER2/insulin-like growth factor receptor signalling and oestrogen receptor activity in clinical breast cancer. Endocrine-Related Cancer 12 Suppl. 1 (2005) S99-S111
15. Grimshaw M.J., Naylor S., and Balkwill F.R. Endothelin-2 is a hypoxia-induced autocrine survival factor for breast tumor cells. Molecular Cancer Therapeutics 1 (2002) 1273-1281
16. Hanifi-Moghaddam P., Gielen S.C., Kloosterboer H.J., De Gooyer M.E., Sijbers A.M., van Gool A.J., Smid M., Moorhouse M., van Wijk F.H., Burger C.W., and Blok C.W.L.J. Molecular portrait of the progestagenic and estrogenic actions of tibolone: behavior of cellular networks in response to tibolone. The Journal of Clinical Endocrinology and Metabolism 90 (2005) 973-983
17. Hodgkinson C.P., Mander A., and Sale G.J. Identification of 80K-H as a protein involved in GLUT4 vesicle trafficking. The Biochemical Journal 388 (2005) 785-793
18. Inoue A., Yoshida N., Omoto Y., Oguchi S., Yamori T., Kiyama R., and Hayashi S. Development of cDNA microarray for expression profiling of estrogen-responsive genes. Journal of Molecular Endocrinology 29 (2002) 175-192
19. Inoue A., Omoto Y., Yamaguchi Y., Kiyama R., and Hayashi S.-I. Transcription factor EGR3 is involved in the estrogen-signaling pathway in breast cancer cells. Journal of Molecular Endocrinology 32 (2004) 649-661
20. Inoue A., Tanji M., and Kiyama R. Focused microarray analysis: characterization of phenomes by gene expression profiling. Current Pharmacogenomics 4 (2006) 245-260
21. Ioannidis J.P.A. Microarrays and molecular research: noise discovery?. Lancet 365 (2005) 454-455
22. Ise R., Han D., Takahashi Y., Terasaka S., Inoue A., Tanji M., and Kiyama R. Expression profiling of the estrogen responsive genes in response to phytoestrogens using a customized DNA microarray. FEBS Letters 579 (2005) 1732-1740
23. Jin V.X., Sun H., Pohar T.T., Liyanarachchi S., Palaniswarny S.K., Huang T.H.M., and Davuluri R.V. ERTargetDB: an integral information resource of transcription regulation of estrogen receptor target genes. Journal of Molecular Endocrinology 35 (2005) 225-230
24. Jordan V.C., Gapstur S., and Morrow M. Selective estrogen receptor modulation and reduction in risk of breast cancer, osteoporosis, and coronary heart disease. Journal of the National Cancer Institute 93 (2001) 1449-1457
25. Katzenellenbogen B.S., Choi I., Delage-Mourroux R., Ediger T.R., Martini P.G., Montano M., Sun J., Weis K., and Katzenellenbogen J.A. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology. The Journal of Steroid Biochemistry and Molecular Biology 74 (2000) 279-285
26. Lehmann L., Esch H.L., Wagner J., Rohnstock L., and Metzler M. Estrogenic and genotoxic potential of equol and two hydroxylated metabolites of Daidzein in cultured human Ishikawa cells. Toxicology Letters 158 (2005) 72-86
27. Leong H., Riby J.E., Firestone G.L., and Bjeldanes L.F. Potent ligand-independent estrogen receptor activation by 3,3′-diindolylmethane is mediated by cross talk between the protein kinase A and mitogen-activated protein kinase signaling pathways. Molecular Endocrinology (Baltimore, Md.) 18 (2004) 291-302
28. Lin C.Y., Strom A., Vega V.B., Kong S.L., Yeo A.L., Thomsen J.S., Chan W.C., Doray B., Bangarusamy D.K., Ramasamy A., Vergara L.A., Tang S., Chong A., Bajic V.B., Miller L.D., Gustafsson J.A., and Liu E.T. Discovery of estrogen receptor alpha target genes and response elements in breast tumor cells. Genome Biology 5 (2004) R66
29. Malyala A., Pattee P., Nagalla S.R., Kelly M.J., and Ronnekleiv O.K. Suppression subtractive hybridization and microarray identification of estrogen-regulated hypothalamic genes. Neurochemical Research 29 (2004) 1189-1200
30. Manning B.D. Balancing Akt with S6K: implications for both metabolic diseases and tumorigenesis. The Journal of Cell Biology 167 (2004) 399-403
31. Matsumura A., Ghosh A., Pope G.S., and Darbre P.D. Comparative study of oestrogenic properties of eight phytoestrogens in MCF7 human breast cancer cells. The Journal of Steroid Biochemistry and Molecular Biology 94 (2005) 431-443
32. Moggs J.G., and Orphanides G. Estrogen receptors: orchestrators of pleiotropic cellular responses. EMBO Reports 2 (2001) 775-781
33. Mueller S.O., Hall J.M., Swope D.L., Pedersen L.C., and Korach K.S. Molecular determinants of the stereoselectivity of agonist activity of estrogen receptors (ER) alpha and beta. The Journal of Biological Chemistry 278 (2003) 12255-12262
34. Nabha S.M., Glaros S., Hong M., Lykkesfeldt A.E., Schiff R., Osborne K., and Reddy K.B. Upregulation of PKC-delta contributes to antiestrogen resistance in mammary tumor cells. Oncogene 24 (2005) 3166-3176
35. Nobukuni T., Joaquin M., Roccio M., Dann S.G., Kim S.Y., Gulati P., Byfield M.P., Backer J.M., Natt F., Bos J.L., Zwartkruis F.J., and Thomas G. Amino acids mediate mTOR/raptor signaling through activation of class 3 phosphatidylinositol 3OH-kinase. Proceedings of the National Academy of Sciences of the United States of America 102 (2005) 14238-14243
36. Osborne C.K., Zhao H., and Fuqua S.A. Selective estrogen receptor modulators: structure, function, and clinical use. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 18 (2000) 3172-3186
37. Peyrat J.P., Bonneterre J., Beuscart R., Djiane J., and Demaille A. Insulin-like growth factor 1 receptors in human breast cancer and their relation to estradiol and progesterone receptors. Cancer Research 48 (1988) 6429-6433
38. Reinholz M.M., An M.W., Johnsen S.A., Subramaniam M., Suman V.J., Ingle J.N., Roche P.C., and Spelsberg T.C. Differential gene expression of TGF beta inducible early gene (TIEG), Smad7, Smad2 and Bard1 in normal and malignant breast tissue. Breast Cancer Research and Treatment 86 (2004) 75-88
39. Rio M.C., and Chambon P. The pS2 gene, mRNA, and protein: a potential marker for human breast cancer. Cancer Cells (Cold Spring Harbor, N.Y.: 1989) 2 (1990) 269-274
40. Soulez M., and Parker M.G. Identification of novel oestrogen receptor target genes in human ZR75-1 breast cancer cells by expression profiling. Journal of Molecular Endocrinology 27 (2001) 259-274
41. Staunton J.E., Slonim D.K., Coller H.A., Tamayo P., Angelo M.J., Park J., Scherf U., Lee J.K., Reinhold W.O., Weinstein J.N., Mesirov J.P., Lander E.S., and Golub T.R. Chemosensitivity prediction by transcriptional profiling. Proceedings of the National Academy of Sciences of the United States of America 98 (2001) 10787-10792
42. Sum E.Y., Peng B., Yu X., Chen J., Byrne J., Lindeman G.J., and Visvader J.E. The LIM domain protein LMO4 interacts with the cofactor CtIP and the tumor suppressor BRCA1 and inhibits BRCA1 activity. The Journal of Biological Chemistry 277 (2002) 7849-7856
43. Tang S.H., Han H., and Bajic V.B. ERGDB: estrogen responsive genes database. Nucleic Acids Research 32 (2004) D533-D536
44. Tanji M., and Kiyama R. Expression profiling of estrogen responsive genes using genomic and proteomic techniques for the evaluation of endocrine disruptors. Current Pharmacogenomics 2 (2004) 255-266
45. Terasaka S., Aita Y., Inoue A., Hayashi S., Nishigaki M., Aoyagi K., Sasaki H., Wada-Kiyama Y., Sakuma Y., Akaba S., Tanaka J., Sone H., Yonemoto J., Tanji M., and Kiyama R. Using a customized DNA microarray for expression profiling of the estrogen-responsive genes to evaluate estrogen activity among natural estrogens and industrial chemicals. Environmental Health Perspectives 112 (2004) 773-781
46. Terasaka S., Inoue A., Tanji M., and Kiyama R. Expression profiling of estrogen-responsive genes in breast cancer cells treated with alkylphenols, chlorinated phenols, parabens, or bis- and benzoylphenols for evaluation of estrogenic activity. Toxicology Letters 163 (2006) 130-141
47. Vivacqua A., Bonofiglio D., Recchia A.G., Musti A.M., Picard D., Ando S., and Maggiolini M. The G protein-coupled receptor GPR30 mediates the proliferative effects induced by 17-estradiol and hydroxytamoxifen in endometrial cancer cells. Molecular Endocrinology (Baltimore, Md.) 20 (2006) 631-646
48. Wang D.Y., Fulthorpe R., Liss S.N., and Edwards E.A. Identification of estrogen-responsive genes by complementary deoxyribonucleic acid microarray and characterization of a novel early estrogen-induced gene: EEIG1. Molecular Endocrinology (Baltimore, Md.) 18 (2004) 402-411
49. Wang D.Y., McKague B., Liss S.N., and Edwards E.A. Gene expression profiles for detecting and distinguishing potential endocrine-disrupting compounds in environmental samples. Environmental Science & Technology 38 (2004) 6396-6406
50. Watanabe H., Suzuki A., Goto M., Lubahn D.B., Handa H., and Iguchi T. Tissue-specific estrogenic and non-estrogenic effects of a xenoestrogen, nonylphenol. Journal of Molecular Endocrinology 33 (2004) 243-252
51. White K.A., Yore M.M., Deng D., and Spinella M.J. Limiting effects of RIP140 in estrogen signaling: potential mediation of anti-estrogenic effects of retinoic acid. The Journal of Biological Chemistry 280 (2005) 7829-7835
52. Wober J., Weisswange I., and Vollmer G. Stimulation of alkaline phosphatase activity in Ishikawa cells induced by various phytoestrogens and synthetic estrogens. The Journal of Steroid Biochemistry and Molecular Biology 83 (2002) 227-233
53. Yarden Y., and Sliwkowski M.X. Untangling the ErbB signalling network. Nature Reviews. Molecular Cell Biology 2 (2001) 127-137
54. Yoo H.H., Kim T., Ahn S., Kim Y.J., Kim H.Y., Piao X.L., and Park J.H. Evaluation of the estrogenic activity of Leguminosae plants. Biological & Pharmaceutical Bulletin 28 (2005) 538-540